SICKLE CELL DISEASE vs. THE CALIFORNIA STEM CELL PROGRAM    Disease-a-week Challenge #19  
    By Don C. Reed  
    Imagine: inside the veins of an African-American child,    red blood cells: round and soft, doing their job, keeping the    person alive.  
    What would happen if those cells hardened and changed    shape, curving into the letter C, like a    wheat-cutting sickle?  
    First, the capillaries would clog, in what Sickle Cell Disease    (SCD) doctors call a crisis. Excruciating agony, like    broken glass in the veins, a crisis may last an hour or a day,    and the pain is just the beginning.  
    By twenty years of age, about 15% of children with SCD suffer    major strokes    by 40 years of age, almost half have central nervous    system damage     cognitive dysfunction (mental problems)  damage to lungs and    kidneys.    frequent hospitalizations (and face the likelihood of) early    death  
        https://www.cirm.ca.gov/...  
    Why does this nightmare condition single out African-Americans?    The carrier state for SCD may be a defense against    malaria, common to sub-Saharan Africa, but the defense is    worse than the disease.  
    Poverty makes things worse: African-Americans are almost    three times more likely than whites to be poor, and accordingly    lack decent medical insurance:  
    The U.S. Census declared in 2010 of the population in    poverty, 9.9% are white persons, 28.4% are black    persons.  
        http://en.wikipedia.org/...  
    Without medical advice, SCD sufferers may not even know even    the most basic care: like the vital importance of drinking    lots of water to stay well-hydrated.  
     The more water a person drinks, the less likely it is    that their abnormal blood cells will clog  
    Another effective treatment is a medication called    hydroxyurea, which reduces crises by 50% and death by 40%, but    most adults are not treated  
    The problem is getting worse. For a person with sickle cell    anemia--  
     the average life expectancy has (gone down) from 42 in 1995    to 39 today.    --     http://www.cirm.ca.gov/...  
    But doesnt the Affordable Care Act (ACA, or Obamacare)    help?  
    Yes, if your state has it. The Affordable Care Act (ACA)    brought reasonably-priced medical care to millions of the poor    and middle class. If someone on Obamacare develops SCD,    medical care and advice is available to them. This is a    wonderful accomplishment, for which history will thank    President Obama.  
    Politics, unfortunately, has gotten in the way.  
    As originally enacted, the ACA required states to expand    Medicaid eligibility to (families)with incomes (close to) the    federal poverty levelHowever, a 2012 Supreme Court ruling made    it optional for states to expand Medicaid eligibility  
    http://www.rand.org/...  
    As of this writing, 21 state governors (all Republicans) have    opted out of ACA: denying affordable medical care to millions    of low-income Americans: including all too many families of    color.   
        http://www.advisory.com/...  
    But access to care is only part of the problem; we also    need to have therapies waiting, actual cures to make people    wellnot just maintain them in their misery.  
    Which brings us to three men connected to the California    Institute for Regenerative Medicine.  
    Bert Lubin is a member of the California Stem Cell Agencys    board of directors.  
    If you live in Oakland, California, you might know Dr. Lubin,    who for more than thirty-six years has been working to save    childrens lives from sickle cell disease.  
    At the Childrens Hospital of Oakland, Dr. Lubin began the    Sibling Donor Cord Blood Program, offered to families across    the United States who have a child with a blood disorder such    as sickle cell anemiaand who are expecting another child.    Following the birth of a healthy child, (his/her cord blood)    is harvested. Because cord blood is enriched with blood-forming    stem cells, it is cryopreserved (frozen) and can be later used    for transplantation. A number of lives have been saved    following transplantation with cord blood units collected in    this program  
    https://www.cirm.ca.gov/...  
    A second champion is Dr. Ted Love, who recently retired from    the board of the California stem cell program.  
    Dr. Love is one of the most genuinely charming people you will    ever meet, and he has a way of calming down arguments that is    amazing to see. When disagreements on the stem cell board got    hot and heavy, he could sum up both sides with a gentle voice,    allowing problems to be settled amicably. When I told him he    would be greatly missed, he said he wanted to dedicate his life    to finding a cure for SCD.  
    How is Dr. Love doing?   
    Helmed by Bay Area biotech veteran Ted Love, Global Blood    Therapeutics is developing treatments for sickle cell disease    a genetic blood disorder that in the U.S. affects 1 in 365    African-Americans  
        http://www.xconomy.com/...  
    The third man is Dr. Donald Kohn of the University of    California at Los Angeles (UCLA), recipient of funding from the    California stem cell program.  
    The following are his own words, taken from public documents.  
    His method?  
    Isolate some of the patients own marrow and then use gene    therapy methods to correct the sickle gene defect in the blood    stem cells before transplanting them back into the patient  
    What would this do?  
     correction of the sickle mutation in adult bone marrow    (blood stem cells) would allow for permanent production of    normal red blood cells each red blood cell (RBC) derived will    produce normal, non-sickle red blood cells  
    What are his hopes?  
    These advances will have direct and immediate applications to    enhance current medical therapies of sickle cell disease  
    Will this information be kept secret, or be shared with other    researchers?  
    All scientific findings and biomedical materials produced from    our studies will be publicly available to non-profit and    academic organizations in California   
    https://www.cirm.ca.gov/...  
    The first clinical trial of stem cell gene therapy has begun    at UCLA and there are great hopes a new therapy will    emerge.Dr. Kohn, personal communication.  
    The struggle is hard. But it must and will go on, funded by    both public and private sources.  
    In our lifetime, will our scientists make an end to this deadly    disease? California intends to find out.  
    Because black lives matter.  
    Don C. Reed is the author of the forthcoming book, STEM CELL    BATTLES: Proposition 71 and Beyond: How Ordinary People Can    Fight Back Against the Crushing Burden of Chronic Disease,    available by pre-order from Amazon.com.        http://www.worldscientific.com/....  
Link:
Sickle Cell Disease vs. the California Stem Cell Agency ...